Fundraising Fox
🦊/Companies
Sign in

Neon Therapeutics

Cambridge, US · Founded 2013 · Delaware corporation · 4 known investors

Find your way into Neon Therapeutics

36 people in our graph share verified history with the Neon Therapeutics team — schools, employers, funds. One of them is your warm intro.

Frank Buckleyunlockedknows Richard Gaynor, M.D. · together at UCLA (overlapped)
×6knows the team · via UCLA
×5knows the team · via The University of Texas Southwestern Medical School
Biotech

Founders & leadership

RGRichard Gaynor, M.D.
Richard Gaynor, M.D.inPresident, Research and Development2016–2020Richard Gaynor is an Executive Officer at Neon Therapeutics, a company developing personalized cancer vaccines based on immuno-oncology approaches. Gaynor holds an M.D. degree.
RA
Robert Ang, M.D.Executive
YAYasir Al-Wakeel
Yasir Al-WakeelinCFO & Head of Strategy2017–2020CEO at Vesalius Therapeutics
EL
Eric LanderNamed on SEC filing
HD
Hugh DowdNamed on SEC filing

Board

CP
Cary Pfeffer, M.D.Board director
RKRobert Kamen
Robert KameninBoard Member2015–2020Venture Partner at Third Rock Ventures
SSStephen Sherwin
Stephen SherwinBoard directorInvestor at Third Rock Ventures
RTRobert Tepper
Robert TepperinBoard directorPartner and co-founder of Third Rock Ventures

Investors · 4

Nextech InvestZurich · $648K – $3.2M
Sofinnova VenturesMenlo Park · $100K – $15M
Clal Biotechnology IndustriesreportedTel Aviv
Third Rock Venturesreported · 2 sourcesBoston · $100K – $5Mvia Robert Kamen · board

Reported raises · per SEC filings

Form D private placements

$106M disclosed across 1 round · 2016

▶$106MraisedDec 2017 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard Gaynor, M.D.Executive Officer
  • Cary Pfeffer, M.D.Director
  • Robert KamenDirector
  • Eric LanderDirector
  • Robert Ang, M.D.Executive Officer
  • Yasir Al-WakeelExecutive Officer
  • Stephen SherwinDirector
  • Hugh DowdExecutive Officer, Director
  • Robert TepperDirector
Offering amount
$106M
Amount sold
$106M
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

After IPO, BioNTech nabs cell therapy startup Neon Therapeutics | Fierce Biotechfiercebiotech.com · Jan 2020Can Neon Therapeutics (NASDAQ:NTGN) Afford To Invest In Growth?finance.yahoo.com · Oct 2019Immuno-oncology player Neon Therapeutics looks for $115M in IPO | Fierce Biotechfiercebiotech.com · Jun 2018Cambridge's Neon Therapeutics Completes $106M Crossover Series B Funding Round - BioSpacebiospace.com · Dec 2017$70M funding sets Neon on course for bright 2017 | Fierce Biotechfiercebiotech.com · Jan 2017Neon Therapeutics Raises $55M Series A Financing - FinSMEsfinsmes.com · Oct 2015

Frequently asked questions

Who are Neon Therapeutics's investors?
Neon Therapeutics's investors include Nextech Invest, Sofinnova Ventures, Clal Biotechnology Industries, Third Rock Ventures.
How much funding has Neon Therapeutics raised?
Neon Therapeutics has disclosed $106M raised across 1 round.
Where is Neon Therapeutics headquartered?
Neon Therapeutics is headquartered in Cambridge, US.